U.S. health officials recommend pneumococcal vaccine for those 50 and older

U.S. health officials now recommend that people aged 50 and older receive the pneumococcal vaccine. This change, approved by the Centers for Disease Control and Prevention, lowers the previous age recommendation from 65. The advisory panel voted 14-1 to make this adjustment, which aims to improve protection against pneumonia and other serious illnesses. The CDC continues to recommend the vaccine for children under 5 and adults 65 and older, as well as those at higher risk. Currently, four pneumococcal vaccines are available, including a new one from Merck that protects against 21 types of bacteria. The CDC's updated guidance reflects ongoing discussions about vaccination needs, particularly for different age groups.